Detalhe da pesquisa
1.
A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease.
Int J Mol Sci
; 23(3)2022 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163772
2.
A flow cytometry-based assay to determine the phagocytic activity of both clinical and nonclinical antibody samples against Chlamydia trachomatis.
Cytometry A
; 93(5): 525-532, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29513398
3.
Quantitative Protein Profiling of Chlamydia trachomatis Growth Forms Reveals Defense Strategies Against Tryptophan Starvation.
Mol Cell Proteomics
; 15(12): 3540-3550, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784728
4.
A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⺠CMI responses protects against a genital infection in minipigs.
Immunol Cell Biol
; 94(2): 185-95, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26268662
5.
Genital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar D.
BMC Vet Res
; 12(1): 200, 2016 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27614611
6.
Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein.
J Infect Dis
; 212(6): 978-89, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25748320
7.
A review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital Chlamydia infection.
Vet Res
; 46: 116, 2015 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26411309
8.
Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach.
Appl Environ Microbiol
; 80(18): 5854-65, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25038093
9.
An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines.
Microb Cell Fact
; 13: 162, 2014 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25421093
10.
Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice.
Nat Commun
; 15(1): 1665, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396019
11.
Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccination.
EBioMedicine
; 104: 105140, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744110
12.
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial.
Lancet Infect Dis
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615673
13.
A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma.
Front Immunol
; 14: 1178741, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287960
14.
A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates.
bioRxiv
; 2023 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36865310
15.
Chlamydia trachomatis vaccine development - a view on the current challenges and how to move forward.
Expert Rev Vaccines
; 21(11): 1555-1567, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004386
16.
Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model.
Front Immunol
; 13: 1057375, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36505459
17.
Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategy.
EBioMedicine
; 84: 104248, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36088218
18.
Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guérin.
J Immunol
; 183(4): 2294-302, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19620310
19.
A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars.
NPJ Vaccines
; 6(1): 58, 2021 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33875654
20.
Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With Chlamydia trachomatis.
Front Immunol
; 12: 790463, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34925371